Researchers developed VISTAQ, a simplified visual method for quantifying heart muscle scarring that achieved 85% sensitivity and 94% specificity in predicting cardiac events among 250 hypertrophic cardiomyopathy patients over five years. The technique subdivides heart segments into mini-segments and classifies scarring visually, requiring only 105 seconds versus 375 seconds for conventional methods. VISTAQ demonstrated excellent reproducibility with correlation coefficients up to 0.98, outperforming traditional automated threshold methods that showed lower event prediction accuracy of 57% sensitivity. This streamlined approach eliminates the need for specialized software and complex contouring procedures that often introduce variability between analysts. The finding addresses a critical bottleneck in cardiac risk assessment, where accurate scar quantification guides treatment decisions including implantable defibrillator placement. However, this multicenter study examined retrospective data, and the visual classification system requires validation across different imaging protocols and reader training levels. As an unreviewed preprint, these results await peer review confirmation. The method's simplicity could democratize advanced cardiac risk stratification, particularly in resource-limited settings, though prospective validation studies will determine whether VISTAQ's promising accuracy translates to improved patient outcomes.